Si-Bone (SIBN) Total Non-Current Liabilities (2017 - 2025)
Si-Bone (SIBN) posted quarterly Total Non-Current Liabilities of $61.0 million for Q4 2025, down 3.84% year-over-year from $63.5 million in Q4 2024, and down 1.81% quarter-over-quarter from $62.1 million in Q3 2025.
Si-Bone (SIBN) Total Non-Current Liabilities (2017 - 2025) Analysis & Trends
Si-Bone's Total Non-Current Liabilities history runs 9 years deep, the most recent figure standing at $61.0 million for Q4 2025.
- In Q4 2025, Total Non-Current Liabilities fell 3.84% year-over-year to $61.0 million; the TTM figure through Dec 2025 stood at $61.0 million (down 3.84% YoY), while the FY2025 annual figure was $61.0 million, down 3.84% from the prior year.
- Total Non-Current Liabilities for Q4 2025 stood at $61.0 million, down from $62.1 million in the prior quarter.
- The five-year high for Total Non-Current Liabilities was $63.5 million in Q4 2024, with the low at $49.5 million in Q3 2021.
- The 5-year median for Total Non-Current Liabilities is $57.7 million (2023), against an average of $57.6 million.
- The sharpest annual moves came in 2022 and 2025: Total Non-Current Liabilities increased 11.96% in 2022, then retreated 3.84% in 2025.
- Si-Bone's Total Non-Current Liabilities stood at $56.0 million in 2021, then gained by 5.7% to $59.2 million in 2022, then grew by 3.06% to $61.0 million in 2023, then climbed by 3.98% to $63.5 million in 2024, then dropped by 3.84% to $61.0 million in 2025.
- Business Quant data shows SIBN's Total Non-Current Liabilities at $61.0 million in Q4 2025, $62.1 million in Q3 2025, and $60.6 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | - |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 21.28 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 40.90 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 42.74 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 2.57 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 3.68 Bn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 23.89 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 9.07 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 3.44 Bn |
| 10 | Si-Bone | 868.19 Mn | 722.25 Mn | 44.55 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 61.02 Mn |
| Sep 30, 2025 | 62.15 Mn |
| Jun 30, 2025 | 60.58 Mn |
| Mar 31, 2025 | 60.02 Mn |
| Dec 31, 2024 | 63.46 Mn |
| Sep 30, 2024 | 62.01 Mn |
| Jun 30, 2024 | 59.10 Mn |
| Mar 31, 2024 | 58.16 Mn |
| Dec 31, 2023 | 61.03 Mn |
| Sep 30, 2023 | 57.26 Mn |
| Jun 30, 2023 | 56.39 Mn |
| Mar 31, 2023 | 55.09 Mn |
| Dec 31, 2022 | 59.22 Mn |
| Sep 30, 2022 | 55.41 Mn |
| Jun 30, 2022 | 55.28 Mn |
| Mar 31, 2022 | 54.37 Mn |
| Dec 31, 2021 | 56.03 Mn |
| Sep 30, 2021 | 49.49 Mn |
| Jun 30, 2021 | 52.25 Mn |
| Mar 31, 2021 | 53.25 Mn |